TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT05669950: A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

Sponsor: H. Lundbeck A/S · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 42 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$1,693,200

Rescue Site Savings

+$1,128,800

Unlock Full NCT05669950 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05669950 Rescue Dossier →